Chronic News and Research

RSS

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

Genentech, Inc., a member of the Roche Group, today announced that the United States Food and Drug Administration has extended the ACTEMRA (tocilizumab, RoACTEMRA in the European Union) label to include inhibition and slowing of structural joint damage, improvement of physical function, and achievement of major clinical response in adult patients with moderately to severely active rheumatoid arthritis, when given in combination with methotrexate.

6 Jan 2011

Columbia research team identifies bacteria may play a key role in atherosclerosis

Dr. Emil Kozarov and a team of researchers at the Columbia University College of Dental Medicine have identified specific bacteria that may have a key role in vascular pathogenesis, specifically atherosclerosis, or what is commonly referred to as "hardening of the arteries" - the number one cause of death in the United States.

6 Jan 2011

Avaxia Biologics generates compelling pre-clinical data in animal models of IBD

Avaxia Biologics, Inc., a privately-held biotech company developing an innovative platform technology to deliver orally-active antibodies to the gastrointestinal tract, announced today that it has generated compelling pre-clinical data in animal models of inflammatory bowel disease.

6 Jan 2011

Study provides new insights into how viruses establish chronic infections

Walter and Eliza Hall Institute researchers in Melbourne, Australia, have discovered how a key viral gene helps viruses evade early detection by the immune system. Their finding is providing new insights into how viruses are able to establish chronic infections, leading scientists to reevaluate their approaches to viral vaccine development.

6 Jan 2011

Bacteria adopt defence strategy to promote antibiotic resistance

Genetic resistance to antibiotics is not the only trick bacteria use to resist eradication- they also have a second defence strategy known as persistence that can kick in.

6 Jan 2011

ODS enters license agreement with Enox Biopharma to develop novel treatment for periodontal disease

Enox Biopharma, a leader in the development of innovative solutions for infections associated with medical devices, and Ortho Dental Solutions LTD today announced an execution of an exclusive royalty bearing license agreement under which Enox Biopharma shall grant Ortho Dental Solutions LTD rights to patent application and knowhow for use in developing novel therapies limited in use for dental and gum diseases.

6 Jan 2011

Study: Antibiotics can provide long-lasting relief to patients with irritable bowel syndrome

A ground-breaking antibiotic therapy developed at Cedars-Sinai Medical Center is the first potential drug treatment to provide irritable bowel syndrome patients with long-lasting relief of their symptoms even after they stop taking the medication, according to a study published in the Jan. 6 issue of the New England Journal of Medicine.

6 Jan 2011

Investigators receive two Alpha-1 Foundation grants for research on lung disorder

The Alpha-1 Foundation announced today that it has awarded two research grants to investigators whose research will contribute to our understanding of the causes and mechanisms that give rise to lung disease.

6 Jan 2011

Maternal depression adversely affects quality of life in children with epilepsy

A study by Canadian researchers examined the prevalence of maternal depression and its impact on children newly diagnosed with epilepsy. Prevalence of depression in mothers ranged from 30%-38% within the first 24 months following a child’s epilepsy diagnosis. The mother’s depressive symptoms negatively impacted the child’s health-related quality of life, but the effects were moderated by the amount of family resources and mediated by how well the family functions and the extent of family demands. Details of this novel study appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

5 Jan 2011

EDMA to endorse the campaign on Hypoparathyroidism

On the occasion of the World Hypoparathyroidism Awareness Day 2011, EDMA, the European Diagnostic Manufacturers Association, highlights the crucial role the In Vitro Diagnostic (IVD) industry can play to effectively testing this rare endocrine condition.

5 Jan 2011

Spectrum Pharmaceuticals enters agreement with Viropro to develop biosimilar rituximab

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has signed a letter of agreement with Viropro, Inc., for the development of a biosimilar version of the monoclonal antibody drug rituximab (marketed by Genentech/Roche). Worldwide sales of rituximab in 2009 in all indications, including non-Hodgkin's lymphoma and chronic lymphocytic lymphoma, were approximately $5.6 billion.

5 Jan 2011

Child's epilepsy diagnosis impacts mother's mental health and family environment

5 Jan 2011

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

The American Heart Association is participating in an international effort to prepare for a United Nations (UN) high-level summit next year on non-communicable diseases (NCDs). These diseases — mainly cardiovascular illnesses including stroke, diabetes, cancer and chronic respiratory conditions — were estimated to cause more than 60 percent of deaths worldwide in 2005.

5 Jan 2011

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

Atherosclerosis is the leading cause of death in the developed world. While a number of risk factors for atherosclerosis have been defined, scientists continue to study other possible risk factors for this disease. Recent epidemiological and experimental studies link infectious agents with the development of inflammatory atherosclerosis. A hallmark of chronic infection with the oral pathogen Porphyromonas gingivalis is the induction of a chronic inflammatory response.

5 Jan 2011

Anti-tobacco laws can reduce smoking habits in Europe

The Global Alliance for Chronic Diseases has announced its intention to release a Request for Applications on Implementation Research on Hypertension in Low and Middle Income Countries.

5 Jan 2011

Dongsheng obtains exclusive sales rights of Thymosin Alpha 1 Injection in China

Dongsheng Pharmaceutical International Co., Ltd. announced today that it has obtained the exclusive sales rights of Thymosin Alpha 1 Injection in 19 provinces in China from Shanghai Biochemistry Pharmaceutical Co. I.

5 Jan 2011

Metabolic cost of missing one night of sleep equivalent to walking two miles

In the first-ever quantification of energy expended by humans during sleep, a University of Colorado team has found that the metabolic cost of an adult missing one night of sleep is the equivalent of walking slightly less than two miles.

5 Jan 2011

Higher measures of walking speed associated with increased length of survival among older adults

In an analysis that included data from 9 studies, having higher measures of walking speed among older adults was associated with increased length of survival, according to a study in the January 5 issue of JAMA.

5 Jan 2011

New wound care eLearning Portal for clinicians

Derma Sciences, a medical device and pharmaceutical company focused on advanced wound care, announces the launch of a new eLearning Portal to provide clinicians with valuable educational programs to ensure they are kept abreast of the latest information and product solutions in the Company's advanced wound care line.

5 Jan 2011

Levindale's Specialty Hospital inagurates high intensity unit

The Specialty Hospital at Levindale has opened Maryland's first high intensity unit inside a chronic hospital. This unit provides heart monitoring for patients who require specialized medical care and treatment for serious illnesses and/or injuries.

5 Jan 2011

Chronic News and Research

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

Columbia research team identifies bacteria may play a key role in atherosclerosis

Avaxia Biologics generates compelling pre-clinical data in animal models of IBD

Study provides new insights into how viruses establish chronic infections

Bacteria adopt defence strategy to promote antibiotic resistance

ODS enters license agreement with Enox Biopharma to develop novel treatment for periodontal disease

Study: Antibiotics can provide long-lasting relief to patients with irritable bowel syndrome

Investigators receive two Alpha-1 Foundation grants for research on lung disorder

Maternal depression adversely affects quality of life in children with epilepsy

EDMA to endorse the campaign on Hypoparathyroidism

Spectrum Pharmaceuticals enters agreement with Viropro to develop biosimilar rituximab

Child's epilepsy diagnosis impacts mother's mental health and family environment

American Heart Association partners in global effort to prepare for UN non-communicable diseases summit

P. gingivalis infection accelerates inflammation and atherosclerosis in the innominate artery

Anti-tobacco laws can reduce smoking habits in Europe

Dongsheng obtains exclusive sales rights of Thymosin Alpha 1 Injection in China

Metabolic cost of missing one night of sleep equivalent to walking two miles

Higher measures of walking speed associated with increased length of survival among older adults

New wound care eLearning Portal for clinicians

Levindale's Specialty Hospital inagurates high intensity unit

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News